PT  - JOURNAL ARTICLE
AU  - Prakash, Meher K.
TI  - Quantitative COVID-19 infectiousness estimate correlating with viral shedding and culturability suggests 68% pre-symptomatic transmissions
AID  - 10.1101/2020.05.07.20094789
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.07.20094789
4099  - http://medrxiv.org/content/early/2020/05/12/2020.05.07.20094789.short
4100  - http://medrxiv.org/content/early/2020/05/12/2020.05.07.20094789.full
AB  - A person clinically diagnosed with COVID 19 can infect others for several days before and after the onset of symptoms. At the epidemiological level, this information on how infectious someone is lies embedded implicitly in the serial interval data. Other clinical indicators of infectiousness based on the temporal kinetics of the viral shedding from the nasopharyngeal swabs and sputum show the former decaying weeks sooner than the latter. In this work, we attempt to provide a better quantitative estimate for the temporal infectiousness profile using serial interval data from a combined 1251 individuals reported in the literature. We show that the infectiousness profile which we calculate correlates well with the viral shedding kinetics from nasopharyngeal swabs (ρ=0.97, p=0.00) and culturability (ρ=0.83, p=0.01). The profile suggests that a 68.4% (95% CI: 67.0-69.7%) of the infections are caused by infections before the symptoms appear, which is a much stronger pre-symptomatic influence than what was predicted in the literature 44% (95% CI: 25-69%) using serial data from 77 individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding has been receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll codes and analysis shall be made available on request